The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Cisplatin and platinum drugs at the molecular level (Review)
Boulikas, T., & Vougiouka, M. (2003) · Oncology Reports · doi:10.3892/or.10.6.1663 · Cited by 729
Conklin, K. A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_1 · Cited by 464
Madias, N. E., & Harrington, J. T. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90825-2 · Cited by 453
OXIDANT MECHANISMS IN TOXIC ACUTE RENAL FAILURE*
BALIGA, R., UEDA, N., WALKER, P. D., & SHAH, S. V. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101947 · Cited by 426
Nazıroğlu, M., Karaoğlu, A., & Aksoy, A. (2003) · Toxicology · doi:10.1016/j.tox.2003.10.012 · Cited by 370
Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells
Townsend, D. M., Deng, M., Zhang, L., Lapus, M. G., & Hanigan, M. H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042803.28024.92 · Cited by 317
Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats
Atessahin, A., Yilmaz, S., Karahan, I., Ceribasi, A. O., & Karaoglu, A. (2005) · Toxicology · doi:10.1016/j.tox.2005.04.016 · Cited by 308
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Rosell, R., Gatzemeier, U., Betticher, D. C., Keppler, U., Macha, H. N., Pirker, R., Berthet, P., Breau, J. L., Lianes, P., Nicholson, M., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf332 · Cited by 299
Erythropoietin protects against ischaemic acute renal injury
Vesey, D. A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg547 · Cited by 286
Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin
Cornelison, T. L., & Reed, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1184 · Cited by 270
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
Ramesh, G., & Reeves, W. B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00401.2004 · Cited by 267
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
Sastry, J., & Kellie, S. J. (2005) · Pediatric Hematology and Oncology · doi:10.1080/08880010590964381 · Cited by 258
Cisplatin-Associated Nephrotoxicity and Pathological Events
Taguchi, T., Nazneen, A., Abid, M. R., & Razzaque, M. S. (2005) · Contributions to Nephrology · doi:10.1159/000086055 · Cited by 256
Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G. W. M., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., Cleton, F. J., & Osanto, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.029 · Cited by 251
Jo, S.-K., Cho, W. Y., Sung, S. A., Kim, H. K., & Won, N. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67102.x · Cited by 235
Naringenin attenuates cisplatin nephrotoxicity in rats
Badary, O. A., Abdel-Maksoud, S., Ahmed, W. A., & Owieda, G. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.11.005 · Cited by 230
Cisplatin nephrotoxicity: experimental and clinical studies.
Daugaard, G. (1990) · PubMed · Cited by 222
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells
Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., & Safirstein, R. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2004 · Cited by 215
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075119 · Cited by 183
Cancer Chemotherapy and Antioxidants
Conklin, K. A. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.3201s · Cited by 181
The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats
Mora, L. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00040-9 · Cited by 175
Liu, H., & Baliga, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00908.x · Cited by 171
Satoh, M., Kashihara, N., Fujimoto, S., Horike, H., Tokura, T., Namikoshi, T., Sasaki, T., & Makino, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047522 · Cited by 156
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats
Shimeda, Y., Hirotani, Y., Akimoto, Y., Shindou, K., Ijiri, Y., Nishihori, T., & Tanaka, K. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1635 · Cited by 140
Effect of Aerva lanata on cisplatin and gentamicin models of acute renal failure
Shirwaikar, A., Issac, D., & Malini, S. (2003) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2003.09.033 · Cited by 137
Theophylline for Prevention of Contrast-Induced Nephropathy
Bagshaw, S. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1087 · Cited by 137
Saad, S. Y., Najjar, T. A. O., & Alashari, M. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.04127.x · Cited by 123
Hu, J., Chen, Y., Zhang, Y., Zhou, M., Song, X., Zhang, B., Luo, L., Xu, P.-M., Zhao, Y.-N., Zhao, Y., et al. (1997) · Biological Trace Element Research · doi:10.1007/bf02785304 · Cited by 123
Çetin, R., Devrím, E., Kılıçoğlu, B., et al. (2005) · Journal of Applied Toxicology · doi:10.1002/jat.1103 · Cited by 122
Cisplatin Nephrotoxicity Is Mediated by Deoxyribonuclease I
Basnakian, A. G., Apostolov, E. O., Yin, X., Napirei, M., Mannherz, H. G., & Shah, S. V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060494 · Cited by 115
Hara, M., Yoshida, M., Nishijima, H., Yokosuka, M., Iigo, M., Ohtani‐Kaneko, R., Shimada, A., Hasegawa, T., Akama, Y., & Hirata, K. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.300301.x · Cited by 113
Protection Effects of Taurine Supplementation against Cisplatin-Induced Nephrotoxicity in Rats
Saad, S. Y., & Al‐Rikabi, A. C. (2002) · Chemotherapy · doi:10.1159/000048587 · Cited by 112
Hartmann, J. T., Fels, L., Knop, S. T., Stolte, H., Kanz, L., & Bokemeyer, C. (2000) · Investigational New Drugs · doi:10.1023/a:1006490226104 · Cited by 110
Totta, P., Acconcia, F., Leone, S., Cardillo, I., & Marino, M. (2004) · IUBMB Life · doi:10.1080/15216540400010792 · Cited by 109
Marina, N. M., Chang, K. W., Malogolowkin, M. H., London, W. B., Frazier, A. L., Womer, R. B., Rescorla, F. J., Billmire, D. F., Davis, M. M., Perlman, E. J., et al. (2005) · Cancer · doi:10.1002/cncr.21218 · Cited by 104
Planting, A. S. T., Catimel, G., Mulder, P. H. M. D., de Graeff, A., Höppener, F., Verweij, I., Oster, W., & Vermorken, J. B. (1999) · Annals of Oncology · doi:10.1023/a:1008353505916 · Cited by 99
Vassallo, R., & Lipsky, J. J. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63701-4 · Cited by 88
The protective effect of melatonin on cisplatin nephrotoxicity
Şener, G., Şatıroğlu, H., Kabasakal, L., et al. (2000) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2000.tb00440.x · Cited by 80
Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice
Kim, S. H., Hong, K. O., Hwang, J. K., et al. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.08.018 · Cited by 61
Saad, S. Y., Najjar, T. A. O., Daba, M. H., & Al‐Rikabi, A. C. (2002) · Chemotherapy · doi:10.1159/000069714 · Cited by 59
Renal toxicities of antineoplastic drugs and bone marrow transplantation.
Berns, J. S., & Ford, P. (1997) · PubMed · Cited by 39
Stress response inhibits the nephrotoxicity of cisplatin
Hanigan, M. H., Deng, M., Zhang, L., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00041.2003 · Cited by 31
Nitric oxide in chronic renal failure
Passauer, J., Pistrosch, F., & Büssemaker, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00259.x · Cited by 30
Effect of Desferrioxamine on Cisplatin-induced Nephrotoxicity in Normal Rats
Al‐Harbi, M. M., Osman, A.-M. M., Al-Gharably, N. M., et al. (2009) · Chemotherapy · doi:10.1159/000239381 · Cited by 29
Verschraagen, M., Boven, E., Torun, E., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.005 · Cited by 19
Watanabe, H., & Kanno, H. (1998) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.101.8_967 · Cited by 15
Cited by
Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
Chirino, Y. I., & Pedraza-Chaverri, J. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2008.09.003 · Cited by 489
Biological effects of gum arabic: A review of some recent research
Ali, B. H., Ziada, A., & Blunden, G. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.07.001 · Cited by 486
Self-citationCisplatin-induced nephrotoxicity and targets of nephroprotection: an update
dos Santos, N. A. G., Carvalho Rodrigues, M. A., Martins, N. M., & dos Santos, A. C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0821-7 · Cited by 378
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 276
Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies
El-Awady, E.-S. E., Moustafa, Y. M., Abo-Elmatty, D. M., & Radwan, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.085 · Cited by 260
Metadata
- Authors
- Ali, B. H., & Al Moundhri, M. S.
- Venue
- Food and Chemical Toxicology
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 44
- Issue
- 8
- Pages
- 1173-1183
- ISSN
- 0278-6915 (ISSN-L)
- OpenAlex
- W2060123651
- Cited by
- 328
- References
- 49
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.